Equifax opened higher at $183.23, compared with its previous close of $179.39. In the last trading session, the stock traded between $181.98 and $186.07. It showed an upward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Equifax is now worth
$ 66.38
resulting in a loss of
$ 33.62 (33.62%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 18 Analysts
Buy
72.22%
Hold
27.78%
Sell
0%
Markets Today
Today's Change
+$4.78 (+2.66%)
Day High
$186.07
Day Low
$181.98
Day Open
$183.23
Prev Close
$179.39
Volume
4,86,382
1W Return
-1.64%
1M Return
30.82%
3M Return
-1.55%
6M Return
6.73%
1Y Return
-14.14%
Fundamentals
Market Cap ($ Mn)
21,551
PE Ratio
34.22
PB Ratio
5.21
PEG Ratio
12.06
ROE
13.58%
ROCE
11.20%
EPS (TTM)
$1.80
Investment Returns
1 Week
-1.64%
1 Month
30.82%
3 Months
-1.55%
6 Months
6.73%
9 Months
-9.72%
Financials
Quarterly
All values in $ Mn
1.5K
Jun 25
1.5K
Sep 25
1.6K
Dec 25
1.6K
Mar 26
1.7K
Jun 26
1.7K
Sep 26
Updates
21Oct
Needham raises Equifax price target to $210, maintains Buy rating
Needham maintains Buy rating on Equifax. Price target raised from $190 to $210. Analyst Kyle Peterson issued the update. Target increase represents $20 uplift.
9 days ago
20Oct
Equifax Q3FY26 Results: EPS up 11% YoY to $2.26, revenue grows 10%
Adjusted EPS rose 11% YoY to $2.26, beating the $2.20 analyst estimate. Revenue increased 10% to $1.693 billion, narrowly surpassing consensus. Full-year revenue outlook lowered to $6.646-$6.676 billion due to mortgage weakness. Q4 guidance issued below Wall Street estimates for both EPS and revenue.
Adjusted EPS of $2.26 beat consensus by 2.73%, up 10.78% YoY. Revenue reached $1.693 billion, growing 9.58% YoY despite mortgage weakness. FY26 EBITDA margin guidance raised to +100 bps due to AI productivity gains. Company returned $158 million to shareholders in Q3, moderating buybacks for Círculo acquisition.
Equifax guides Q4 adjusted EPS to $2.07-$2.17, below the $2.20 analyst estimate. Projected sales of $1.605B-$1.635B miss the $1.692B consensus forecast. Both revenue and earnings guidance fall short of Wall Street expectations.
10 days ago
20Oct
Equifax FY26 Results: Sales guidance cut to $6.646B-$6.676B
Equifax lowered FY26 sales guidance to $6.646B-$6.676B from $6.710B-$6.780B. Revised sales outlook is below the analyst estimate of $6.736B. Adjusted EPS guidance narrowed to $8.45-$8.55 from $8.39-$8.69. New EPS range straddles the $8.50 analyst estimate.
10 days ago
19Oct
Mizuho keeps Outperform on Equifax, cuts price target to $185
Mizuho analyst Sean Kennedy maintained an Outperform rating on Equifax. The price target was lowered from $210 to $185. The revision reflects a $25 reduction in valuation expectations.
